Ornithogalum Umbellatum 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234641) held by Dolisos Canada Inc., containing Ornithogalum Umbellatum. Health Canada lists its status as Cancelled Post Market (status date 01 Aug 2007). Nexara Health has matched 12 registrations of Ornithogalum Umbellatum across 1 other regulated market.
Health Canada registration
| DIN | 02234641 |
|---|---|
| Brand name | Ornithogalum Umbellatum |
| Active ingredient | Ornithogalum Umbellatum |
| Strength | 1 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 01 Aug 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Ornithogalum Umbellatum registered in other markets
12 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Bach Original Flower Remedies | Nelson Bach USA Limited | Solution | listed | FDA NDC | |
| United States | Bach Original Flower Remedies Star of Bethlehem | Nelson Bach USA Limited | Solution | listed | FDA NDC | |
| United States | Ornithogalum umbellatum | Boiron | Pellet | listed | FDA NDC | |
| United States | Ornithogalum Umbellatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Ornithogalum Umbellatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Ornithogalum Umbellatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Ornithogalum Umbellatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Ornithogalum Umbellatum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Ornithogalum Umbellatum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ornithogalum Umbellatum (DIN 02234641) marketed in Canada?
No. Health Canada lists DIN 02234641 as Cancelled Post Market as of 01 Aug 2007.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Ornithogalum Umbellatum registered outside Canada?
Yes — Nexara Health has matched 12 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234641, status date 2007-08-01; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234641, status date 2007-08-01; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02234641, status date 2007-08-01; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.